争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2020
疫苗試驗參與者起訴印度血清研究所
提起诉讼
一名 Covishield 疫苗試驗參與者起訴印度血清研究所，聲稱接種試驗疫苗後出現嚴重神經功能損害。他要求 5 億盧比賠償。報導未確認其所稱因果關係已獲裁定。
一名 Covishield 疫苗试验参与者起诉印度血清研究所，声称接种试验疫苗后出现严重神经功能损害。他要求 5 亿卢比赔偿；报导未确认其所称因果关系已获裁定。
品牌回应
否认 — Serum Institute of India
The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer's medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer.
否认 — Serum Institute of India
The firm has also said the man's illness had nothing to do with the vaccine trials.
来源摘录
The man has sought Rs 5 crore as compensation.
A 40-year-old Chennai-based participant in the trial for the Covishield vaccine developed by the Pune-based Serum Institute of India has sued the company, claiming he has suffered serious neurological impairment after the under-trial coronavirus vaccine was administered to him, PTI reported on Sunday.
A 40-year-old volunteer for 'Covishield', the candidate vaccine being tested by the Pune-based Serum Institute of India (SII), has sued the company for ₹5 crore, alleging that the vaccine triggered an adverse reaction, which includes neurological impairment and an inability to get back to the life before being inoculated.